Clinical Trial: A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Brief Summary: This study will evaluate the efficacy and safety of OC5 in patients with PH.

Detailed Summary:
Sponsor: OxThera

Current Primary Outcome: Change from baseline in plasma oxalate concentration after 52 weeks of treatment [ Time Frame: 52 weeks ]

Change from baseline in plasma oxalate concentration after 52 weeks of treatment


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: OxThera

Dates:
Date Received: April 7, 2017
Date Started: October 2017
Date Completion: September 2019
Last Updated: April 14, 2017
Last Verified: April 2017